Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Embolization Stories

2010-08-03 09:00:00

TUSTIN, Calif., Aug. 3 /PRNewswire/ -- MicroVention, Inc., a leading developer, manufacturer and marketer of interventional neurovascular devices, announced today that the final 18-month follow-up data in an international study showed that its innovative HydroCoil® Embolic System for treating cerebral aneurysms reduced recurrence and retreatment rates and provided improved outcomes in study patients when compared to bare platinum coils, which are considered the standard...

2010-07-29 08:32:00

WALTHAM, Mass., July 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets. Although novel devices in the embolization coil market have shown...

2010-05-27 03:28:00

PARIS, May 27, 2010 /PRNewswire/ -- - New Trial Results on ExoSeal(TM) Vascular Closure Device Support its Clinical Safety* and Efficacy Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device. ExoSeal(TM) incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Cordis...

2010-05-13 12:22:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...

2010-05-13 08:00:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...

2010-05-11 16:28:00

EDMONTON, May 11 /PRNewswire/ - IMBiotechnologies Ltd. ("IMBio"), a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration (FDA) to market its lead product, Occlusin(R) 500 Artificial Embolization Device (OCL 500) in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours. IMBio filed the...

2010-03-16 09:30:00

Contributions of Society of Interventional Radiology members through medical patents, patent applications continue to alter medical landscape to improve patient care Over the past 40 years, more than 2,400 patents and patent applications"”pioneering modern medicine with the devices and drugs that advance minimally invasive treatments"”have been filed by members of the Society of Interventional Radiology. These innovations"”from the invention of angioplasty and the...

2010-03-16 08:00:00

Direct Injection of Gold Nanoparticles Into Tumors Opens Door to New and Future Treatment for Most Fatal Cancer TAMPA, Fla., March 16 /PRNewswire-USNewswire/ -- Pancreatic cancer--known as the most fatal cancer with no known effective treatment--requires a radical new therapy. A promising approach may come in the form of tiny gold nanoparticles--loaded with a therapeutic agent to kill cancer--in a novel procedure called "nanoembolization," said researchers at the Society of...

2010-03-15 13:14:09

MR-guided focused ultrasound offers women another minimally invasive treatment to remove uterine fibroids"”avoiding surgical myomectomy and hysterectomy TAMPA, Fla. -- There's a new interventional radiology tool showing promise in the treatment of uterine fibroids: magnetic resonance-guided focused ultrasound (MRgFUS), a minimally invasive treatment that uses high-energy ultrasound waves to generate heat at a specific point to destroy uterine fibroid tissue and relieve symptoms. A study...

2010-03-15 13:11:53

First global study indicates comparable fertility rates for minimally invasive UFE and 'gold standard' surgical myomectomy for women who want to have children after uterine fibroid treatment TAMPA, Fla. -- Uterine fibroid embolization, a minimally invasive interventional radiology procedure that blocks blood supply to treat painful uterine fibroids, has a comparable fertility rate to myomectomy, the surgical removal of uterine fibroids, for women who want to conceive, according to the first...


Latest Embolization Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »